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Abstract
Introduction: Coeliac disease enteropathy is associated with an increased risk of lymphomas. 
Enteropathy-associated T-cell lymphoma is the principal malignancy related to coeliac disease. 
However, studies have shown that other types of lymphoma such as diffuse large B-cell lymphoma 
may also be associated with coeliac disease. Case Report: We report a 54-year-old Caucasian man 
who presented with chronic diarrhoea and weight loss. He was diagnosed with coeliac disease based 
on positive serology results and duodenal, jejunal, and ileal biopsies that showed villous atrophy. 
Despite adherence to a gluten-free diet, there was no clinical remission and enteropathy-associated 
T cell lymphoma was suspected. Repeated endoscopic biopsy showed persistent mucosal disease but 
no evidence of lymphoma. Several weeks later he presented with a perforated jejunum. Histology of 
the resected jejunum showed diffuse infiltration of submucosa and muscularis propria by malignant 
lymphoid cells sparing the mucosa. The cells expressed CD20, CD79α, CD10 and BCL6 and ki67 of 
80%, consistent with diffuse large B-cell lymphoma. Discussion: It is suspected that the undetected 
lymphoma may have contributed to the persistent malabsorption syndrome rendering the patient 
unresponsive to treatment. Despite thorough clinical and endoscopic evaluation and multiple biopsies, 
histologic diagnosis of DLBCL was only confirmed following resection of the perforated jejunum. 
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CASE REPORT
INTRODUCTION
Coeliac disease is a chronic immune-mediated 
enteropathy which is induced by dietary gluten 
in genetically susceptible individuals.1 It has a 
worldwide distribution and commonly affects 
the European populations with a prevalence of 
about 1%.1 It is associated with complications 
such as osteopenia, infertility, autoimmune 
diseases, immune deficiencies, infections and 
malignancies.2 The risk factors for developing 
complications include persistent exposure to 
dietary gluten, chronic mucosal inflammation 
and genetic factors.2 There is a strong association 
between coeliac disease and lymphoma, 
particularly the rare enteropathy-associated 
T-cell lymphoma (EATL) type 1 which accounts 
for about 30% of the cases.3,4,5 However, some 
studies have suggested that other types of 
lymphomas are more frequently associated with 
coeliac disease.3,4 These lymphomas include 
unspecified peripheral T-cell lymphoma, diffuse 
large B-cell lymphoma (DLBCL) and mucosa-
associated lymphoid tissue (MALT) lymphoma.3,4 
Here, we report a case of DLBCL of the small 
intestine arising in a patient with refractory 
coeliac disease.
CASE REPORT
A 54-year-old Caucasian man presented to 
our centre with generalised lethargy, weight 
loss and persistent diarrhoea for one year. 
He was pre-morbidly well and had been in 
Malaysia for the past 20 years. There was no 
family history of coeliac or other autoimmune 
diseases. Clinically, he was cachexic and had 
bilateral pedal oedema. Oral aphthous ulcers, 
skin rashes, peripheral neuropathy as well as 
other features to suggest autoimmune disease 
were absent. His blood investigations showed 
low total protein [35 g/L (normal range: 64-83 
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g/L)] and serum albumin [17 g/L (normal range: 
35-50 g/L)] levels, normochromic normocytic 
anaemia [haemoglobin 10 g/dL (normal range: 
13.5-17.4 g/dL)] with a normal iron status. His 
IgM, IgA and IgG levels were also low. Serum 
endomysial and anti-tissue transglutaminase 
antibodies were not performed. A colonoscopy 
was performed for chronic diarrhoea and showed 
a typical mosaic appearance of the small bowel 
mucosa consistent with coeliac disease. An ileal 
biopsy was performed at this point (Table 1, 
Fig. 1) which revealed villous atrophy consistent 
with Modified Marsh Classification Type 3a 
coeliac disease. 
 The patient was subsequently started on 
gluten-free diet. However, his symptoms 
FIG. 1: Ileal biopsy showed (A) moderate mucosal damage with partial villous atrophy and crypt destruction and 
(B) increased number of intraepithelial lymphocytes.
TABLE 1: Summary of the intestinal biopsies performed: Microscopic findings and pathologi-
cal diagnoses
No.	 Biopsy	 Indication	 Microscopic	findings	 Interpretation
1.	 Terminal	 To	confirm	 Moderate	mucosal	damage	with	 Coeliac	disease,		
	 ileal	biopsy	 the	diagnosis		 partial	villous	atrophy	and	crypt	 Modified	Marsh
	 at	diagnosis	 of	coeliac		 destruction.	Intraepithelial	 Classification	Type	3a
	 	 disease	 lymphocytosis	was	present.
	 	 	 IHC	showed	reactive	T	and	B
	 	 	 cells	(retrospective).	
2. Duodenal	 To	re-assess	 Severe	active	duodenitis	with	 Superimposed	H. 
	 biopsy	12		 the	mucosal	 partial	villous	blunting.	There	 pylori	infection	on
	 months		 disease	 was	increased	intraepithelial	 an	underlying
	 after		 following	 lymphocytes.	Helicobacter coeliac	disease
	 diagnosis	 gluten-free	 pylori was	present.	
	 	 diet	 IHC	showed	reactive	T	and	B	
	 	 	 lymphocytes.	
3. Jejunal	 Suspected		 Partial	villous	blunting	and	 Consistent	with
	 biopsy	12		 lymphoma,	 flattening.	No	abnormal	 refractory	coeliac
	 months		 to	exclude	 lymphocytes	seen.	 disease.	No	evidence
	 after		 EATL	 IHC	showed	reactive	and	non-	 of	EATL.
	 treatment	 	 neoplastic	T	and	B	
	 	 	 lymphocytes.	
Note: In view of high suspicion of lymphoma, immunohistochemical study for B- and T-cells was performed 
on the three biopsies to look for evidence of lymphoma. However, immunohistochemical study results showed 
that there was no evidence of lymphoma in all the biopsy samples. Abbreviation: IHC, immunohistochemistry; 
EATL, enteropathy-associated T-cell lymphoma.
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persisted despite 12 months of strict compliance 
with gluten-free diet. Gastroendoscopy revealed 
mucosal atrophy of the duodenum (Table 1) with 
superimposed Helicobacter pylori. A diagnosis of 
chronic active duodenitis on underlying coeliac 
disease was made. At this time a magnetic 
resonance enterography (MRE) was performed 
and showed thickening of the small bowel wall 
at the level of proximal and mid-jejunum with 
multiple enlarged mesenteric lymph nodes 
measuring up to 2.0 cm. These findings were 
compatible with small bowel lymphoma. It was 
thus concluded that the patient had refractory 
coeliac disease and that the findings of the MRE 
were strongly suspicious that there was also 
EATL of the small intestine. An oral-route double 
balloon enteroscopy was performed and the 
suspicious jejunal lesion was biopsied (Table 1). 
The biopsy showed mucosal damage but no 
evidence of EATL or any malignancy. Five weeks 
later, he developed an acute abdomen due to a 
perforated jejunum. An emergency laparotomy 
was performed and the perforated jejunum was 
resected.
Pathological findings 
The resected jejunum measured 250 mm in 
length and 40 mm in diameter with attached 
mesenteric fat. The wall was thickened around 
the perforation site. A small polyp measuring 10 
mm greatest area dimension was also present. 
Microscopically, diffuse malignant lymphoid 
cells comprised medium to large cells were seen 
mainly within the submucosa with infiltration 
into the serosa (Fig. 2). In areas, there was 
spillage of the tumour cells into the lamina 
FIG. 2: (A) Diffuse infiltration of malignant lymphoid cells predominantly the submucosa. (B) The cells were 
composed of medium to large cells and displayed pleomorphic nuclei with prominent nucleoli and scant 
cytoplasm. The cells expressed (C) CD20, (D) CD10 (weak), and (E) BCL6. (F) The proliferative index 
(Ki-67) was 80%. 
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propria. Malignant lymphoid cells were also 
seen within the small polyp. The cells displayed 
large and pleomorphic nuclei with prominent 
nucleoli and scant cytoplasm. Mitoses were 
numerous with areas of necrosis were observed. 
Immunohistochemical studies showed that the 
malignant lymphoid cells expressed CD20, 
CD79α, CD10 (weak) and BCL6. Ki-67 showed 
a high proliferative index (80%) (Fig. 2). These 
cells were negative for CD3, CD5, CD7, CD8, 
TIA-1, MUM1, cyclin D1 and CD56. A diagnosis 
of DLBCL was made. Twenty-one lymph nodes 
were identified and none of the lymph nodes 
showed malignant infiltration. Elsewhere the 
mucosa showed focal blunting of the villi with 
increased intraepithelial lymphocytes.
Clinical course
Post-operatively, he developed intra-abdominal 
sepsis secondary to anastomotic leak and 
underwent a second laparotomy for further 
small bowel resection and double-barrel stoma 
creation. A positron emission tomography-
computed tomography (PET-CT) did not show 
any active disease elsewhere. Bone marrow 
biopsy showed normocellular marrow with 
no evidence of lymphomatous infiltration. He 
was diagnosed with stage I disease and was 
counselled for chemotherapy. 
 He was given gluten-free diet supplemented 
with parenteral nutrition. His adherence of 
gluten-free diet was monitored and his general 
condition improved. Subsequently, he underwent 
reversal of ileostomy and was finally discharge 
after three months of hospitalisation. 
DISCUSSION
The association between sprue-like syndrome 
and lymphoma was first described by Fairley and 
Mackie in 1937.6 Recent studies demonstrated 
a three- to six-fold increased risk of lymphoma 
incidence which is much lower than the earlier 
estimates of risk.3,4 This decline may have been 
due to early detection and treatment of coeliac 
disease.7 More than half of the lymphoma cases in 
coeliac disease were of primary gastrointestinal 
origin while the remaining were extraintestinal.3 
Patients with coeliac disease and small intestinal 
lymphoma present with non-specific symptoms 
such as abdominal pain, diarrhoea, weight loss 
and rarely presented with complications such 
as perforation, haemorrhage and obstruction.1,4,8 
The jejunum is the most common site of coeliac 
disease-associated gastrointestinal lymphoma 
followed by ileum, stomach and colon.4,8 
 The present patient showed lack of initial 
response to gluten-free diet. Although radiological 
examination was highly suspicious of lymphoma, 
initial biopsies failed to show the lymphoma 
cells. The main reason the biopsies did not 
show the malignant cells was because they were 
superficial (mucosal layer only) whereas the 
malignant lymphoid cells were predominantly in 
the submucosa. Repeated biopsies are frequently 
necessary before the correct diagnosis is finally 
made.9 In such difficult cases, full thickness 
laparoscopic biopsies are sometimes required.8 
 The commoner type of lymphoma associated 
with coeliac disease is EATL type 1. EATL type 
1 frequently shows a large-cell and pleomorphic 
morphology. In contrast, EATL type 2 which is 
less frequently associated with coeliac disease has 
a more monomorphic cytology.10 Recent studies 
have found an increased risk for B-cell neoplasm 
commonly DLBCL.3,4 Histologically, both EATL 
type 1 and DLBCL display medium-sized to large 
cells with vesicular nuclei, prominent nucleoli 
and moderate to abundant pale cytoplasm. 
Immunohistochemical profile of the tumours 
is clearly distinct. In EATL, the tumour cells 
express CD3, CD7, CD103 and TIA-1 with loss 
of CD5, CD4 and CD8 expression. However, in 
DLBCL the neoplastic cells express pan B-cell 
markers such as CD20 and CD79α with further 
subgrouping by combination of immunomarkers 
CD10, BCL6 and MUM1. Both tumours show 
high proliferative index by Ki-67 staining and 
may be positive for CD30.11 Clinically, patients 
with B-cell lymphoma have better survival rate 
than those with T-cell lymphoma.3,4 
CONCLUSION
We described a case of DLBCL of the jejunum 
in a patient with refractory coeliac disease 
where initial biopsies failed to detect the tumour. 
Diagnosis of lymphoma was only achieved on the 
resected jejunum following intestinal perforation. 
This case illustrates the need for careful clinical 
and pathological evaluation of patients with non-
responsive coeliac disease for the possibility of 
underlying lymphoma.
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